To evaluate the antibody responses to influenza in transgenic mice with a humanized B-cell repertoire, specifically the Intelliselect transgenic mouse (Kymouse).
Key Findings:
Kymouse is susceptible to H1N1, H3N2, and B/Yamagata influenza viruses.
The Kymouse generates robust binding and neutralizing antibody responses to all tested influenza strains.
The study demonstrates the utility of human B-cell repertoire mice for influenza virus research.
Interpretation:
The Kymouse model provides a valuable tool for understanding human-like antibody evolution and responses to influenza vaccination and infection.
Limitations:
The study is limited to the specific strains of influenza tested.
Potential differences in immune responses between Kymouse and actual human responses.
Conclusion:
The Kymouse model can significantly aid in the development of universal influenza vaccines by providing insights into human antibody responses.
Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.
